Lori J. Braender
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lori J. Braender
Aquestive Therapeutics, Inc. reported in an 8-K filed March 20, 2026 that Lori J. Braender resigned as Chief Legal Officer and Chief Compliance Officer, effective April 2, 2026. The proxy statement of Aquestive Therapeutics, Inc. reports total compensation of $1,348,238 for Lori J. Braender in fiscal 2025, including a base salary of $457,962. Disclosed compensation is on record for 4 fiscal years.
“On March 16, 2026, Aquestive Therapeutics, Inc. (the "Company") and Lori J. Braender, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary of the Company, agreed that Ms. Braender will step down from her Chief Legal Officer and Chief Compliance Officer roles and will no longer serve as an executive officer of the Company, effective April 2, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Aquestive Therapeutics, Inc. (AQST)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2026-04-02
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aquestive Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Barber CEO, Board Member
- Gregory B. Brown Chairman
- John S. Cochran Chairman
- A. Ernest Toth CFO
- A. Ernest Toth, Jr. CFO
- Cassie Jung COO
- Thomas A. Zalewski General Counsel
- Abigail L. Jenkins Board Member
- Julie Krop Board Member
- Marco Taglietti Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aquestive Therapeutics, Inc. (AQST) | Corporate Secretary, Former Chief Legal Officer and Chief Compliance Officer\ | $457,962 | $1,348,238 |
| 2024 | Aquestive Therapeutics, Inc. (AQST) | Chief Legal Officer, Chief Compliance Officer and Corporate Secretary | $444,402 | $1,821,025 |
| 2023 | Aquestive Therapeutics, Inc. (AQST) | Chief Legal Officer, Chief Compliance Officer and Corporate Secretary | $417,300 | $1,146,828 |
| 2022 | Aquestive Therapeutics, Inc. (AQST) | Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | $412,575 | $935,910 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.